Perspective Therapeutics Inc CATX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.05
- Day Range
- $3.01–3.17
- 52-Week Range
- $1.96–5.89
- Bid/Ask
- $3.16 / $3.17
- Shares Outstanding
- 114.05M
- Market Cap
- $358.68M
- Volume/Avg
- 900,828 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 166
Valuation
|
Metric
|
CATX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.00 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CATX
|
|---|---|
Quick Ratio | 8.61 |
Current Ratio | 8.75 |
Interest Coverage | −339.98 |
Quick Ratio
CATX
Profitability
|
Metric
|
CATX
|
|---|---|
Return on Assets (Normalized) | −31.70% |
Return on Equity (Normalized) | −37.95% |
Return on Invested Capital (Normalized) | −40.21% |
Return on Assets
CATX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|zlWfFG? | LOCK|>Mvm | $155B | |||
| Stryker Corp
SYK
| LOCK|&J&#M?l | LOCK|vTN | $119B | |||
| Medtronic PLC
MDT
| LOCK|mV^QVH | LOCK|my?y! | $102B | |||
| Boston Scientific Corp
BSX
| LOCK|tt^$D# | LOCK|^B@%k | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|z&@<FYT | LOCK|zx?$> | $52B | |||
| DexCom Inc
DXCM
| LOCK|SLTTjf^l | LOCK|C^@@ | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Q#&zs! | LOCK|%!? | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|pGf | LOCK|>H | $25B | |||
| Steris PLC
STE
| LOCK|<&sdT<l | LOCK|@>Pq% | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!z!y$@q% | LOCK|ZR# | $18B |
United States